삼아제약

009300KOSDAQ의약품 제조업

55.0 / 100

Reference Date: 2026-07-24

Financial Score27.5 / 40

News Sentiment12.5 / 25

Momentum5.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Slightly down 2.3% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Samah Pharmaceutical is a pharmaceutical company specializing in the production and sale of respiratory, dermatological, and analgesic drugs, along with health functional foods. It operates a state-of-the-art production facility established in 2009 at the Munmak plant. However, revenue declined by 18.6% year-on-year in 2023 due to a decrease in respiratory patients, with respiratory drugs (67.7%) and analgesics (13.2%) contributing the majority of sales.

Number of Employees

310people

Average Salary

56.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

5.87Industry Average 11.236.5Point

Lower than industry avg (good)

PBR

0.35Industry Average 0.817.0Point

Half of industry avg (excellent)

ROE

5.78Industry Average 4.014.0Point

In line with industry avg

Debt Ratio

2.21Industry Average 12.438.0Point

Half of industry avg (excellent)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼10.1% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼25.5% (2-year basis)

ROE Trend

2.0 / 4

Avg ROE 9.2% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 12,450Won52-week high 18,62052-week low 12,210

1-month return2.0Point

1m -2.28% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0